Infinity Pharmaceuticals, Inc. Revenue
Infinity Pharmaceuticals, Inc. reported Revenue of $583.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2023-08-10
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-06-30 was $583.00K, a 15.01% decline year-over-year.
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-03-31 was $731.00K, a 12.12% increase year-over-year.
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-12-31 was $543.00K, a 20.40% increase year-over-year.
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-09-30 was $712.00K, a 66.36% increase year-over-year.
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $2.59M, a 39.56% increase from fiscal 2021.
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $1.86M, a 8.09% increase from fiscal 2020.
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $1.72M, a 43.62% decline from fiscal 2019.
- Infinity Pharmaceuticals, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2019 was $3.05M, a 86.23% decline from fiscal 2018.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2023-06-30 | $583.00K 10-Q · filed 2023-08-10 | $1.31M 10-Q · filed 2023-08-10 | $1.86M derived: sum of 3 quarters · filed 2023-08-10 | $2.57M derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $731.00K 10-Q · filed 2023-05-09 | $1.27M derived: sum of 2 quarters · filed 2023-05-09 | $1.99M derived: sum of 3 quarters · filed 2023-05-09 | $2.67M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | $543.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $1.25M derived: sum of 2 quarters · filed 2023-03-28 | $1.94M derived: sum of 3 quarters · filed 2023-08-10 | $2.59M 10-K · filed 2023-03-28 |
| 2022-09-30 | $712.00K 10-Q · filed 2022-11-14 | $1.40M derived: sum of 2 quarters · filed 2023-08-10 | $2.05M 10-Q · filed 2022-11-14 | $2.50M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | $686.00K 10-Q · filed 2023-08-10 | $1.34M 10-Q · filed 2023-08-10 | $1.79M derived: sum of 3 quarters · filed 2023-08-10 | $2.22M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $652.00K 10-Q · filed 2023-05-09 | $1.10M derived: sum of 2 quarters · filed 2023-05-09 | $1.53M derived: sum of 3 quarters · filed 2023-05-09 | $2.04M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $879.00K derived: sum of 2 quarters · filed 2023-03-28 | $1.39M derived: sum of 3 quarters · filed 2023-03-28 | $1.86M 10-K · filed 2023-03-28 |
| 2021-09-30 | $428.00K 10-Q · filed 2022-11-14 | $940.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.41M 10-Q · filed 2022-11-14 | $1.84M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $512.00K 10-Q · filed 2022-08-09 | $979.00K 10-Q · filed 2022-08-09 | $1.42M derived: sum of 3 quarters · filed 2022-08-09 | $1.91M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $467.00K 10-Q · filed 2022-05-03 | $903.00K derived: sum of 2 quarters · filed 2022-05-03 | $1.40M derived: sum of 3 quarters · filed 2022-05-03 | $1.76M derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $932.00K derived: sum of 2 quarters · filed 2022-03-29 | $1.29M derived: sum of 3 quarters · filed 2022-03-29 | $1.72M 10-K · filed 2022-03-29 |
| 2020-09-30 | $496.00K 10-Q · filed 2021-11-02 | $856.00K derived: sum of 2 quarters · filed 2021-11-02 | $1.28M 10-Q · filed 2021-11-02 | $1.59M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $360.00K 10-Q · filed 2021-07-27 | $788.00K 10-Q · filed 2021-07-27 | $1.10M derived: sum of 3 quarters · filed 2021-07-27 | $1.44M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | $428.00K 10-Q · filed 2021-05-13 | $736.00K derived: sum of 2 quarters · filed 2021-05-13 | $1.08M derived: sum of 3 quarters · filed 2021-05-13 | $1.34M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $651.00K derived: sum of 2 quarters · filed 2021-03-16 | $908.00K derived: sum of 3 quarters · filed 2021-03-16 | $3.05M 10-K · filed 2021-03-16 |
| 2019-09-30 | $343.00K 10-Q · filed 2020-11-09 | $600.00K derived: sum of 2 quarters · filed 2020-11-09 | $2.74M 10-Q · filed 2020-11-09 | $2.89M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $257.00K 10-Q · filed 2020-07-30 | $2.40M 10-Q · filed 2020-07-30 | $2.54M derived: sum of 3 quarters · filed 2020-07-30 | $24.55M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $2.14M 10-Q · filed 2020-05-11 | $2.29M derived: sum of 2 quarters · filed 2020-05-11 | $24.29M derived: sum of 3 quarters · filed 2020-05-11 | $24.29M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $22.15M derived: sum of 2 quarters · filed 2020-03-03 | $22.15M derived: sum of 3 quarters · filed 2020-03-03 | $22.15M 10-K · filed 2020-03-03 |
| 2018-09-30 | $22.00M 10-Q · filed 2019-10-30 | $22.00M derived: sum of 2 quarters · filed 2019-10-30 | $22.00M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-07-30 | $0.00 10-Q · filed 2019-07-30 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $6.00M 10-K · filed 2019-03-14 |